MedTrace Logo

Remifentanil and Nitroprusside for Controlled Hypotension

NCT02001298 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-12-04

No results posted yet for this study

Summary

The purpose of this study is the comparison of the cardiovascular effects of remifentanil and nitroprusside for controlled hypotension

Conditions

  • Hypotension, Controlled

Interventions

DRUG

remifentanil

DRUG

nitroprusside

Sponsors & Collaborators

  • Jeju National University School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02001298 on ClinicalTrials.gov